Corcept Therapeutics | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
Alaunos Therapeutics USD 1.09M 592K 2024-12
ANI Pharmaceuticals USD 217.8M 67.99M 2025-06
Ardelyx USD 48.65M 8.78M 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
BioMarin Pharmaceutical USD 1.21B 601.78M 2025-06
Bristol-Myers Squibb USD 12.6B 1.72B 2025-06
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 102.74M 12.93M 2025-06
Eli Lilly USD 3.38B 282.6M 2025-06
J&J USD 38.47B 32.35B 2025-03
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Merck USD 8.01B 622M 2025-06
Novartis USD 6.66B 410M 2025-06
Novartis USD 11.46B 2.15B 2024-12
Pacira USD 300.48M 16.87M 2025-06
Pfizer USD 1.64B 208M 2025-06
Supernus Pharmaceuticals USD 144.71M 28.86M 2025-06
TG Therapeutics USD 278.86M 146.72M 2025-06


Corcept Therapeutics Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.